2025

Patent Granted in China (miRNA as biomarker for Parkinson's disease)

Selected for R&D project by the Ministry of SMEs and Startups

2024

Selected for R&D project by the Ministry of SMEs and Startups

Completion of Startup Leap Package Support Project

Selected for Deep-Tech TIPS project (Fast track) by the Ministry of SMEs and Startups

2023

Selected for Startup Leap Package Support Project project by the Ministry of SMEs and Startups

HQ & Corporate Research Institute Relocation (Seongdong-gu Knowledge Industry Center, Seoul)

Attracted strategic investment from Asan Pharm

Received the BEST Award for Diagnostics & Laboratory Equipment at the MEDITEK Innovation Awards.

2022

Patent Granted in US, Japan (miRNA as biomarker for Parkinson's disease)

Signed MOU with Dong-A ST

Attracted angel investment

Selected as a Promising Leading Company in Seoul's 4 Future Growth Industries

Completion of R&D project by the Ministry of SMEs and Startups

2021

Selected for an R&D project (1) by Korea Health Industry Development Institute

Selected for an R&D project by the Ministry of SMEs and Startups

Selected for an R&D project (2) by Korea Health Industry Development Institute

Completion of R&D project (1) by Korea Health Industry Development Institute

2020

Attracted financial investment from Korea Venture Investment Corp .

Corporate Research Institute established

Securing additional research space in Seoul Biohub

Successfully completed R&D project by the Ministry of Science and ICT

2019

Selected as a resident company of Seoul Biohub

Attracted angel investment

Selected for R&D project by the Ministry of Science and ICT

Venture company certification